ArticleTherapeutics and clinical risk management2011

New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond.

Bruno Gori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.